New product release pairs daily wellness gummy with an extensive research review analyzing Maca, Ashwagandha, Green Tea, and Caffeine human clinical trials.
HILLIARD, Ohio, September 16, 2026 — SodaPeak, a new multi-ingredient dietary supplement manufactured in the United States, today officially announced the nationwide availability of its daily gummy formulation alongside an extensive research review detailing the scientific evidence behind its key functional ingredients.
Designed as a convenient once-daily gummy to support overall vitality, energy, and wellness routines, the SodaPeak formula features six botanical extracts and active compounds: Maca extract, Ashwagandha, Green Tea extract, Caffeine, Muira Puama extract, and Catuaba extract. To provide full transparency to consumers, SodaPeak accompanied its product launch with an evidence-based overview distinguishing clinically studied ingredients from traditional botanical uses.
The scientific foundation for the formula highlights ingredients with robust human clinical research. Double-blind, placebo-controlled trials evaluate Maca root for supporting perceived energy and well-being, while standardized Ashwagandha extracts have been extensively studied in controlled clinical trials for reducing stress and fatigue. Additionally, Caffeine and Green Tea polyphenols represent two of the most widely researched ingredients for physical endurance, alertness, and cognitive performance.
By pairing product availability with detailed scientific context, SodaPeak aims to establish a research-forward standard in the dietary supplement industry, encouraging consumers to review clinical data and consult product specifications for precise active ingredient quantities.
SodaPeak’s publicly available product pages reviewed for this release do not state an individual milligram amount for each of the six listed ingredients. Because those quantities are not publicly established on the pages reviewed, this release does not characterize any ingredient as being included at a clinically established dose.
Instead, the research below provides context about what scientists have studied while identifying important limitations where appropriate.
Maca Research Includes Human Studies on Energy and General Well-Being
Maca, botanically known as Lepidium meyenii, is a plant native to the Andean region of South America and has a history of use as both a food and traditional botanical preparation.
Among the ingredients listed by SodaPeak, Maca has a comparatively developed human-research record.
A randomized, double-blind, placebo-controlled study involving 175 adults evaluated spray-dried red or black Maca extracts at 3 grams daily for 12 weeks. Researchers evaluated multiple health and quality-of-life measures and reported differences in areas including perceived energy, mood and health-related quality of life among participants receiving the Maca preparations. The investigators also noted differences between the red and black varieties.
The study is useful evidence that Maca has been investigated directly in humans, but it does not establish that every Maca supplement will produce equivalent outcomes.
The trial used specified varieties, a defined 3-gram daily quantity and a 12-week intervention. SodaPeak’s current public webpage identifies Maca extract as an ingredient but does not disclose an individual amount or enough extract specifications to establish equivalence with that study.
More recent research has continued to investigate Maca in exercise-related settings. A 2025 randomized crossover trial involving 10 trained college basketball players evaluated 2,000 mg of Maca daily for two weeks and measured several sport-specific and fatigue-related outcomes. The small participant group and specialized population mean those findings should be interpreted cautiously rather than generalized broadly.
Together, the research supports describing Maca as a botanical with published human investigation. It does not justify promising a particular outcome from an undisclosed amount in a different formulation.
Additional product information is available official website.
Ashwagandha Has Been Studied for Stress and Fatigue-Related Measures
Ashwagandha, or Withania somnifera, is another botanical with a substantial body of human research.
The National Center for Complementary and Integrative Health states that many clinical studies have investigated ashwagandha, although differences in preparation, participant population and trial design make broad conclusions difficult. NCCIH reports that some preparations may help with stress and sleep, while evidence for many other proposed uses remains insufficient.
A randomized, double-blind, placebo-controlled trial published in 2026 studied a low-dose standardized ashwagandha extract in 60 adults experiencing self-reported stress. Participants received 30 mg per day or placebo for 28 days. Researchers evaluated perceived stress, mood, fatigue and physiological responses to a controlled stress procedure.
The researchers noted that many earlier ashwagandha studies had evaluated quantities ranging approximately from 250 to 600 mg daily over six to eight weeks, highlighting how significantly formulations can differ. This variation makes the exact product specification important.
Simply stating that a formula contains ashwagandha does not establish that it matches a particular extract evaluated in a controlled trial. Root-only extracts, root-and-leaf extracts, withanolide concentrations and extraction methods can differ among commercial preparations.
Because SodaPeak’s public product material reviewed here does not state the individual ashwagandha amount or standardization, findings from existing trials should be understood as research on ashwagandha preparations rather than clinical evidence for the SodaPeak finished formula.
Safety also deserves context. NCCIH notes that short-term ashwagandha use may be tolerated by many people but that side effects and interactions are possible. Individuals taking medications or managing existing health conditions should discuss botanical supplementation with an appropriate healthcare professional.
Green Tea Extract Has Been Evaluated Across Multiple Human Research Settings
Green tea is produced from Camellia sinensis and contains naturally occurring polyphenols, including compounds known as catechins. Green tea and concentrated green tea extracts have been investigated in numerous human studies, although the composition of individual preparations varies substantially.
One controlled study involving trained amateur athletes investigated 500 mg of green tea extract daily for 15 days during repeated exercise sessions. Researchers evaluated measures related to muscle damage, oxidative stress and neuromuscular activity.
Another randomized placebo-controlled study involving non-trained men also used 500 mg per day for 15 days. Researchers found differences in certain laboratory markers after strenuous exercise, although reported muscle soreness did not change.
These studies demonstrate that concentrated green tea preparations have been evaluated experimentally in people, but they should not be interpreted as proof of a generalized energy or performance effect.
The National Center for Complementary and Integrative Health additionally notes that green tea contains numerous compounds and that evidence remains insufficient for many of the broad health outcomes commonly associated with green tea supplements. Product composition can substantially influence results.
This is particularly important for SodaPeak because the public formula separately lists both green tea extract and caffeine. The amount and composition of the green tea extract are not disclosed on the pages reviewed. Without those details, it is not possible to determine from the website alone whether the extract contains additional caffeine or how much catechin material is present.
Consumers should therefore rely on the current Supplement Facts panel on their physical product for exact quantities rather than estimating exposure from general research.
Caffeine Has One of the Most Extensively Studied Evidence Bases in the Formula
Caffeine is the SodaPeak ingredient with perhaps the largest body of controlled human research. A major scientific review examining caffeine and cognitive, physical and occupational performance found that low-to-moderate quantities have been associated in controlled research with effects on alertness, vigilance, attention and reaction time. Effects on higher-order cognitive functions have been less consistent.
Exercise research has also evaluated caffeine extensively. An umbrella review of published meta-analyses found evidence across a range of physical-performance outcomes, although the authors emphasized that evidence quality and effect certainty differed between outcomes.
Another systematic review of randomized studies involving endurance activities found a small average performance effect when moderate caffeine quantities were used, while also documenting meaningful differences among individual responses.
These findings show why caffeine is considered a well-researched dietary compound, but dose remains central to interpretation. Many exercise studies use caffeine quantities calculated according to body weight. Cognitive studies also evaluate specific measured amounts.
SodaPeak’s current public product pages do not disclose the amount of caffeine supplied by one gummy. It would therefore be inappropriate to cite research conducted at a particular caffeine quantity as evidence that SodaPeak will produce the same result.
The U.S. Food and Drug Administration states that for most adults, 400 mg of caffeine per day is an amount not generally associated with negative effects, while emphasizing that sensitivity varies according to factors including body weight, medications and individual response. Excessive intake can cause unwanted effects.
Anyone using multiple caffeine-containing foods, beverages or supplements should consider their total daily intake rather than evaluating each source in isolation.
Muira Puama Has Experimental Research, but Controlled Human Evidence Remains Limited
Muira Puama is commonly associated with Ptychopetalum olacoides, a plant native to the Amazon region.
Published research has examined extracts of Ptychopetalum olacoides in laboratory and animal models. For example, researchers have investigated its effects on cholinergic enzyme activity and memory-related experimental endpoints. These findings provide a basis for further scientific investigation but do not constitute evidence of comparable outcomes in people. Human research is substantially more limited.
One published 28-day human safety study evaluated a multi-herb preparation containing Muira Puama together with several other botanical ingredients. Researchers did not report severe adverse reactions or significant hematological or biochemical changes during that study.
However, because Muira Puama was only one component of the preparation, the research cannot determine the independent contribution of Muira Puama. The distinction between an experimental botanical study and a controlled clinical efficacy trial is particularly important here.
It would be inaccurate to characterize Muira Puama as clinically established for energy, stamina, focus or another defined outcome based on the currently available evidence cited in this review. A more scientifically appropriate description is that the botanical has undergone experimental investigation while controlled human evidence remains limited.
Catuaba Research Is Primarily Preclinical
Catuaba is a traditional Brazilian botanical name that can refer to material derived from different plant species.
One species frequently investigated in scientific literature is Trichilia catigua. Researchers have examined Trichilia catigua extracts for antioxidant activity and fatigue-related outcomes in experimental models. A published study evaluated several extracts in laboratory assays and animal models of fatigue, stress and memory and reported biological activity worthy of additional research.
These findings should nevertheless be classified correctly. They are preclinical findings rather than evidence that a Catuaba-containing dietary supplement produces the same effects in people.
Another challenge involves botanical identity. Research examining commercially available Catuaba preparations has found variation in the plant species used under the Catuaba name. That means the exact species and extract specification are important when comparing a commercial ingredient with published scientific literature.
The SodaPeak website reviewed for this release identifies Catuaba extract but does not provide a botanical species, extraction ratio, standardization or individual quantity. Without those details, it is not scientifically appropriate to assume that research involving Trichilia catigua or another Catuaba species directly applies to the ingredient used in the product.
Catuaba should therefore be described as a traditionally used botanical with published experimental research, while acknowledging the limited controlled human evidence and variability among preparations.
Research on Individual Ingredients Does Not Establish the Finished Formula
SodaPeak combines six listed ingredients in a once-daily gummy format. That multi-ingredient design raises a separate scientific question from whether individual ingredients have been investigated independently.
A clinical study on 3 grams of Maca does not demonstrate what happens when an unspecified amount of Maca is combined with five additional ingredients. Similarly, research using a standardized ashwagandha extract cannot automatically be transferred to an ashwagandha ingredient without knowing whether the extracts are comparable.
Caffeine research is strongly dose-dependent, while studies involving green tea use extracts that can differ in catechin composition and caffeine content. Muira Puama and Catuaba have an additional limitation because controlled human evidence is comparatively sparse.
For these reasons, phrases such as “clinically proven formula” or “clinically proven ingredients at effective doses” would require evidence beyond the information currently available on SodaPeak’s public product pages.
A more accurate interpretation is that the formula includes ingredients with differing levels of scientific investigation, ranging from extensive human research in the case of caffeine to mainly experimental research for certain botanicals.
Ingredient Transparency Remains Important for Research Comparisons
The SodaPeak website states that the supplement is manufactured in the United States using globally sourced ingredients and recommends one gummy daily. For consumers attempting to compare the product with published research, however, the Supplement Facts panel remains especially important.
Research comparisons are most informative when the following details are available: the quantity of each active ingredient, the botanical species, plant part, extraction method, standardization level and total caffeine content per serving.
Without those details, consumers and researchers cannot reliably determine whether a commercial preparation resembles the preparations used in published trials.
“Scientific research is most useful when ingredient evidence and finished-product evidence are kept separate,” said a SodaPeak spokesperson. “Our goal is to encourage consumers to look at the complete formula, understand the research context and maintain realistic expectations about what dietary-supplement studies can establish.”
A Research-Aware Approach to Daily Supplementation
Dietary-supplement research continues to evolve as researchers study individual nutrients, botanicals, standardized extracts and multi-ingredient products. Evidence should be interpreted according to the actual study rather than reduced to broad marketing statements.
A randomized human trial provides a different level of information from an animal study. A laboratory experiment can identify mechanisms worth investigating but does not demonstrate a consumer outcome. A trial involving a branded standardized extract does not necessarily apply to every extract from the same plant. Likewise, statistically significant results do not mean that every participant will experience a noticeable change.
Individual factors including diet, sleep, activity level, caffeine consumption, medications and health status can also affect how people respond to dietary supplements. Consumers with medical conditions or those taking prescription medications should discuss supplement use with an appropriate healthcare professional, particularly when formulas combine botanical extracts with caffeine.
About SodaPeak
SodaPeak is a gummy-format dietary supplement manufactured in the United States with globally sourced ingredients. Its current public product materials list Muira Puama extract, Maca extract, Catuaba extract, green tea extract, caffeine and ashwagandha as components of the formula. The product is designed for once-daily use as part of a broader wellness routine.
Additional product information and current purchasing terms are available through the official SodaPeak website.
Media Contact
Kevin Learne
Media Relations, SodaPeak
Email: contact@customercs.com
Phone: +1 (855) 889-3137
Address: Address: P.O. Box 12730, Ogden, UT 84412, USA
Important Notice
This release discusses published research for informational purposes. Research involving individual ingredients, different botanical extracts, different quantities, different formulations or different study populations should not be interpreted as demonstrating equivalent outcomes from the SodaPeak finished formula.
Experimental laboratory and animal findings are identified separately from human clinical research and should not be interpreted as evidence of demonstrated effects in people.
Individual responses to dietary supplements may vary. SodaPeak is a dietary supplement and is not intended to diagnose, treat, cure or prevent any disease. Dietary supplements are not substitutes for professional medical advice, diagnosis or treatment.
